{"nct_id":"NCT03833167","title":"Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2019-04-01","start_date_type":"ACTUAL","primary_completion_date":"2024-06-28","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-22","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}